Keyphrases
ACK1
100%
Prostate Cancer
65%
Tyrosine Kinase
49%
Androgen Receptor
46%
TNK2
42%
Receptor Tyrosine Kinase
34%
Phosphorylation
32%
Castration-resistant Prostate Cancer
27%
Acetylation
18%
HOXB13
18%
Apoptosis
15%
Tyrosine
14%
Gene Expression
14%
Androgen Production
13%
Histone H2A
13%
Cancer Cells
12%
Activated Cdc42-associated Kinase
10%
Androgens
9%
WEE1
9%
Green Fluorescent Protein
9%
Mitochondria
9%
MerTK
9%
Tyrosine Phosphorylation
9%
5-hydroxymethylcytosine (5hmC)
8%
Breast Cancer Susceptibility
8%
Epigenetic Reprogramming
8%
Cell Cycle Genes
8%
SREBF1
8%
Cyclin-dependent Kinase 4 (CDK4)
8%
Anticancer Immune Response
8%
Prostate Cancer Cells
8%
Epigenetics
8%
In Cancer
8%
Small Molecule Inhibitors
7%
DNA Damage Response
7%
Single-molecule Fluorescence Resonance Energy Transfer (smFRET)
7%
Cdc42
7%
Cancer Cell Proliferation
7%
Mammalian Cells
6%
Novel Therapeutics
6%
Androgen Receptor Expression
6%
Isocitrate Dehydrogenase 1 (IDH1)
6%
Prostate
6%
Tumor
6%
Wwox
6%
Oncogene
6%
Tumor Suppressor
6%
Protein-protein Interaction
6%
Epigenetic Marks
5%
Chromatin
5%
Biochemistry, Genetics and Molecular Biology
Receptor Tyrosine Kinase
66%
Tyrosine Kinase
54%
Kinase
48%
Phosphotransferase
48%
Androgen Receptor
44%
Epigenetics
40%
Cancer Cell
36%
Tyrosine
27%
Gene Expression
16%
Acetylation
16%
Histone
16%
Non-Receptor Tyrosine Kinase
16%
HOXB13
13%
Androgen Synthesis
13%
Histone H2A
13%
Tyrosine Phosphorylation
13%
Mitochondrion
11%
Cell Cycle
10%
Tumor Progression
10%
Epidermal Growth Factor Receptor
9%
Oncogene
9%
Transcription
8%
SREBF1
8%
CDC42
8%
Reprogramming
8%
Green Fluorescent Protein
8%
5-Hydroxymethylcytosine
8%
Homeostasis
8%
C-Terminus
8%
Carcinogenesis
7%
Estrogen Receptor
7%
Cell Death
7%
Mammalian Cell
7%
Tumor Suppressor Protein
7%
Signal Transduction
7%
T Cell
6%
Enzyme
6%
Fluorescence Resonance Energy Transfer
6%
Enhancer Region
6%
Small Molecule
6%
Cell Survival
5%
Hormone Receptor
5%
CDC20
5%
Demethylase
5%
Histone Gene
5%
Phosphatidylinositol
5%
Histone H4
5%
Drug Sensitivity
5%
Upregulation
5%
Cell Cycle Checkpoint
5%
Medicine and Dentistry
Prostate Cancer
44%
Protein Tyrosine Kinase
32%
Androgen Receptor
26%
Cancer Cell
24%
Breast Cancer
14%
Cancer Growth
12%
Phosphotransferase
12%
Neoplasm
11%
Androgen
9%
Cancer Resistance
8%
5 Hydroxymethylcytosine
8%
Cell Cycle
8%
Epidermal Growth Factor Receptor
8%
Programmed Cell Death
8%
Malignant Neoplasm
7%
Castration Resistant Prostate Cancer
7%
Protein Phosphorylation
7%
Oncogene
7%
Kinase Signaling
6%
Prostate Hypertrophy
6%
Homeostasis
6%
Cell Proliferation
6%
Gene Expression
6%
Breast Tumor
5%
Tamoxifen
5%
Histone Demethylase
5%
Drug Sensitivity
5%
Histone
5%
Receptor Expression
5%
Estrogen Receptor
5%
